We are live on ! Find out more
ISL

Ingalls & Snyder LLC Portfolio holdings

AUM $2.83B
1-Year Est. Return 21.61%
This Fund
S&P 500
This Quarter Est. Return
+9.1%
1 Year Est. Return
+21.61%
3 Year Est. Return
+166.27%
5 Year Est. Return
+212.01%
10 Year Est. Return
+695.23%
AUM
$2.14B
AUM Growth
+$116M
Cap. Flow
-$26.7M
Cap. Flow %
-1.25%
Top 10 Hldgs %
33.75%
Holding
461
New
36
Increased
115
Reduced
195
Closed
23

Top Buys

Rank Stock Value
1
DE icon
Deere & Co
DE
+$4.94M
2
STM icon
STMicroelectronics
STM
+$4.34M
3
FROG icon
JFrog
FROG
+$3.94M
4
MO icon
Altria Group
MO
+$3.73M
5
IDN icon
Intellicheck
IDN
+$3.01M

Top Sells

Rank Stock Value
1
CORT icon
Corcept Therapeutics
CORT
+$9.49M
2
AAPL icon
Apple
AAPL
+$9.19M
3
GM icon
General Motors
GM
+$5.02M
4
GS icon
Goldman Sachs
GS
+$4.66M
5
CSCO icon
Cisco
CSCO
+$3.79M

Sector Composition

Rank Sector Weight
1 Healthcare 22.27%
2 Technology 14.4%
3 Financials 13.66%
4 Energy 11.86%
5 Industrials 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTX icon
376
Vertex Pharmaceuticals
VRTX
$121B
$258K 0.01%
1,200
TKR icon
377
Timken Company
TKR
$9.56B
$255K 0.01%
3,147
-16
-0.5% -$1.28K
WAL icon
378
Western Alliance Bancorporation
WAL
$8.79B
$252K 0.01%
+2,671
New +$221K
FIS icon
379
Fidelity National Information Services
FIS
$23.1B
$251K 0.01%
1,783
-113
-6% -$15.4K
BKI
380
DELISTED
Black Knight, Inc. Common Stock
BKI
$251K 0.01%
3,392
-245
-7% -$19.7K
BABA icon
381
Alibaba
BABA
$293B
$249K 0.01%
1,100
-167
-13% -$41K
CCI icon
382
Crown Castle
CCI
$33.3B
$249K 0.01%
1,446
IDXX icon
383
Idexx Laboratories
IDXX
$44.1B
$249K 0.01%
508
+2
+0.4% +$1K
WBS icon
384
Webster Financial
WBS
$12.5B
$247K 0.01%
+4,475
New +$238K
DAL icon
385
CALL
Delta Air Lines
DAL
$57.5B
$246K 0.01%
5,100
NJR icon
386
New Jersey Resources
NJR
$5.84B
$245K 0.01%
6,145
-24
-0.4% -$915
COF icon
387
Capital One
COF
$128B
$241K 0.01%
+1,895
New +$223K
SMED
388
DELISTED
Sharps Compliance Corp
SMED
$240K 0.01%
16,700
-22,549
-57% -$290K
ALL icon
389
Allstate
ALL
$68B
$237K 0.01%
2,066
RXT icon
390
Rackspace Technology
RXT
$1.05B
$236K 0.01%
+9,912
New +$214K
NG icon
391
NovaGold Resources
NG
$2.56B
$234K 0.01%
26,700
EBS icon
392
Emergent Biosolutions
EBS
$373M
$229K 0.01%
2,467
-46
-2% -$4.71K
GS icon
393
CALL
Goldman Sachs
GS
$300B
$229K 0.01%
700
-400
-36% -$125K
XLU icon
394
State Street Utilities Select Sector SPDR ETF
XLU
$22.8B
$221K 0.01%
6,916
YUM icon
395
Yum! Brands
YUM
$41.8B
$221K 0.01%
2,040
AXTA icon
396
Axalta
AXTA
$7.66B
$220K 0.01%
7,445
MTCH icon
397
Match Group
MTCH
$9.19B
$220K 0.01%
1,600
MIK
398
CALL
DELISTED
Michaels Stores, Inc
MIK
$217K 0.01%
9,900
-100
-1% -$1.77K
TECK icon
399
Teck Resources
TECK
$29.6B
$216K 0.01%
+11,250
New +$228K
DVLT
400
Datavault AI
DVLT
$291M
$216K 0.01%
5

Similar funds

Ingalls & Snyder LLC's Q1 2021 Portfolio in Review

As of Q1 2021, Ingalls & Snyder LLC held 461 positions worth $2.14B, up 5.8% from $2.03B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Ingalls & Snyder LLC's Q1 2021 filing shows 36 new, 115 increased, 195 reduced and 23 closed positions. Its largest new stake was JFrog: 68,342 shares worth $3.03M. The largest sale was Corcept Therapeutics, an estimated $9.49M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 24% a quarter earlier, followed by Technology and Financials.

  • Ingalls & Snyder LLC's largest Q1 2021 buy was JFrog: 68,342 shares worth $3.03M.
  • Ingalls & Snyder LLC added most to Deere & Co in Q1 2021, an estimated $4.94M increase.
  • Ingalls & Snyder LLC's biggest Q1 2021 reduction was Corcept Therapeutics, cutting an estimated $9.49M.
  • Ingalls & Snyder LLC fully exited Agenus in Q1 2021, selling an estimated $636K.
  • Ingalls & Snyder LLC's ten largest holdings make up 34% of its $2.14B portfolio in Q1 2021.
  • Ingalls & Snyder LLC opened 36 new positions and closed 23 in Q1 2021.
  • Ingalls & Snyder LLC's portfolio value rose 5.8% quarter-over-quarter to $2.14B.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2021, filed 21 Apr 2021.